Ironwood Financial’s Alexion Pharmaceuticals ALXN Stock Holding History

Ironwood Financial’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-9	Closed	-$1K	–	585
2020 Q4	$1K	Hold	9	–	–	﹤0.01%	476
2020 Q3	$1K	Hold	9	–	–	﹤0.01%	427
2020 Q2	$1K	Hold	9	–	–	﹤0.01%	398
2020 Q1	$1K	Hold	9	–	–	﹤0.01%	342
2019 Q4	$1K	Hold	9	–	–	﹤0.01%	371
2019 Q3	$1K	Hold	9	–	–	﹤0.01%	376
2019 Q2	$1K	Hold	9	–	–	﹤0.01%	371
2019 Q1	$1K	Hold	9	–	–	﹤0.01%	367
2018 Q4	$1K	Hold	9	–	–	﹤0.01%	358
2018 Q3	$1K	Buy	+9	New	+$1.13K	﹤0.01%	354
2015 Q1	–	Sell	-1	Closed	–	–	470
2014 Q4	$0	Buy	+1	New	+$185	﹤0.01%	430

Other funds holding ALXN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return

HBK Investments Dallas, Texas $7.94B AUM 55.6% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Davidson Kempner Capital Management New York $4.65B AUM 56.47% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return